Table 3.

Meta-regression results (p values). Significant p-values are bolded for emphasis

	LS		LSRs		CS		RS
Variable	b (95 % CI)	p	b (95 % CI)	p	b (95 % CI)	p	b (95 % CI)	p
Age	0.06 (-0.03 to 0.16)	0.18	0.04 (0.02 to 0.05)	<0.001	-0.07 (-0.26 to -0.11)	0.45	0.16 (-1.01 to 1.33)	0.78
Male gender	0.02 (-0.02 to 0.06)	0.31	0.002 (-0.004 to 0.009)	0.49	-0.01 (-0.07 to 0.05)	0.76	0.13 (-0.7 to 0.95)	0.75
BSA	-0.24 (-1.64 to 1.15)	0.73			-1.71 (-4.25 to 0.82)	0.18	0.14 (-15.59 to 15.87)	0.98
HR	-0.004 (-0.03 to 0.02)	0.76			0.01 (-0.02 to 0.06)	0.48	-0.12 (-0.46 to 0.21)	0.47
SBP	-0.02 (-0.08 to 0.04)	0.51
DBP	-0.08 (-0.18 to 0.02)	0.13
LVEDD	0.3 (0.13 to 0.47)	<0.001
LV mass	0.01 (-0.05 to 0.08)	0.57			-0.03 (-0.22 to 0.15)	0.71
LV model	0.99 (-0.18 to 2.17)	0.1	0.32 (-0.1 to 0.75)	0.14
Tissue tracking	-0.68 (-1.79 to 0.42)	0.22
Vendor	0.92 (-0.07 to 1.92)	0.08	0.15 (-0.1 to 0.41)	0.25	0.59 (-0.36 to 1.56)	0.22	-6.59 (-11.3 to -1.91)	0.005
Probe	-0.70 (-1.29 to -0.1)	0.02			1.36 (-0.08 to 2.81)	0.07
FR	0.007 (-0.01 to 0.03)	0.51	-0.001 (-0.006 to 0.002)	0.40	0.07 (-0.09 to 0.23)	0.38	0.55 (-0.71 to 1.82)	0.39